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Abstract
Migraine is a recurrent pain condition traditionally viewed as a neurovascular disorder, but
little is known of its vascular basis. In epidemiological studies migraine is associated with an
increased risk of cardiovascular disease, including coronary artery disease (CAD), suggest-
ing shared pathogenic mechanisms. This study aimed to determine the genetic overlap
between migraine and CAD, and to identify shared genetic risk loci, utilizing a conditional
false discovery rate approach and data from two large-scale genome-wide association
studies (GWAS) of CAD (C4D, 15,420 cases, 15,062 controls; CARDIoGRAM, 22,233
cases, 64,762 controls) and one of migraine (22,120 cases, 91,284 controls). We found sig-
nificant enrichment of genetic variants associated with CAD as a function of their association
with migraine, which was replicated across two independent CAD GWAS studies. One
shared risk locus in the PHACTR1 gene (conjunctional false discovery rate for index SNP
rs9349379 < 3.90 x 10−5), which was also identified in previous studies, explained much of
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the enrichment. Two further loci (in KCNK5 and AS3MT) showed evidence for shared risk
(conjunctional false discovery rate < 0.05). The index SNPs at two of the three loci had
opposite effect directions in migraine and CAD. Our results confirm previous reports that
migraine and CAD share genetic risk loci in excess of what would be expected by chance,
and highlight one shared risk locus in PHACTR1. Understanding the biological mechanisms
underpinning this shared risk is likely to improve our understanding of both disorders.
Introduction
Migraine is a recurrent pain condition which affects some 14% of the general population and
is ranked as the 7th leading cause of disability worldwide [1–3]. In about one third of patients,
headache attacks are preceded by transient neurological symptoms, termed migraine aura [2].
The pathogenic mechanisms of migraine are incompletely understood, but the disorder has a
considerable genetic component with an estimated heritability of 42% [4]. There has been a
long-standing debate over whether migraine is primarily a disorder of vascular or neuronal
origin, but the more recent view favors a neuronal origin [5, 6]. Several arguments exist, how-
ever, why a partly vascular pathology in migraine should not be dismissed. First, migraine is
associated with a range of vascular disorders [7], most notably, individuals with migraine have
a two-fold increased risk of experiencing an ischemic stroke, a risk that is most apparent for
migraine with aura [8]. More recently, a similar risk increase has been reported for coronary
artery disease (CAD) suggesting a relation between migraine and vascular pathology outside
the cerebral circulation [9, 10]. Second, migraine patients more often report a family history
of early CAD, suggesting a possible shared genetic basis between both disorders [11]. Last,
genetic loci associated with migraine appear to be enriched for genes expressed in vascular and
smooth muscle tissues, pointing towards vascular mechanisms [12].
Recent large-scale genome-wide association studies (GWAS) allow for the interrogation of
shared genetic risk factors between traits [13]. If migraine and CAD have a partly shared path-
ogenic basis, it is likely that they also share genetic risk factors, which has indeed been found
for migraine and stroke [14] and migraine and CAD [15, 16], respectively. Here we aimed to
further investigate the polygenic overlap between migraine and CAD, and to identify common
susceptibility gene loci pointing to shared mechanisms in both disorders. To this end we made
use of three large-scale GWAS of CAD and migraine, together with a newly developed method
that utilizes a conditional false discovery rate (FDR) approach. This approach has been used to
identify shared risk loci and potential novel susceptibility variants for a number of diseases
and phenotypes, including schizophrenia [17, 18], bipolar disorder [17], prostate cancer [19],
hypertension [20], primary sclerosing cholangitis [21], and Alzheimer’s disease [22].
Materials and methods
Participant samples
Analyses are based on three large GWAS meta-analyses of migraine and CAD (Fig 1).
Details about recruitment, phenotyping, genotyping and association analyses are provided
in the original publications [23–25]. Migraine GWAS summary statistics results (P-values and
z-scores) were obtained from the International Headache Genetics Consortium (IHGC) [24]
and entailed 23,285 migraine cases and 95,425 controls. Through public-access websites, we
obtained the summary statistics for two GWAS of CAD, C4D [23] with 15,420 cases and
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15,062 controls, and CARDIoGRAM [25] with 22,233 cases and 64,762 controls. To achieve
independence between the migraine and CAD datasets we re-performed the IHGC migraine
meta-analysis without the 1958 Birth Cohort (B58C) (thereby excluding 1,165 cases and 4,141
controls), leaving the migraine and C4D datasets without overlapping samples. For compari-
son with CARDIoGRAM we re-performed the migraine analysis without B58C and deCODE
cohorts (thereby excluding 3,304 cases and 38,758 controls). This left an overlap of 834 con-
trols from GERMIFS III (KORA), which was also part of the German MO migraine sub-study.
This overlap was deemed minimal (representing < 1.5% of the controls in the CARDIoGRAM
and migraine studies). As excluding the German MO cohort (the largest clinical migraine
cohort) would substantially reduce the overall power of the migraine analysis, this cohort was
kept in the analysis. This resulted in two migraine datasets with 22,120 and 19,981 cases, and
91,284 and 56,667 controls, for comparison with C4D and CARDIoGRAM, respectively. The
two CAD GWAS studies, C4D and CARDIoGRAM, contained no overlapping samples.
The study was approved by the Regional Committee for Ethics in Medical Research, Nor-
way (#2012/229/REK sor-ost C). The relevant institutional review boards or ethics committees
approved the research protocol of the individual GWAS studies used in the current analysis,
and all human participants gave written informed consent.
Statistical analyses
Conditional Q-Q plots for cross-phenotype enrichment. To visually assess cross-pheno-
type enrichment, we used modified quantile-quantile (Q-Q) plots for association to CAD con-
ditioned on ‘cross-phenotype’ effects (Fig 2a and 2b), described in detail previously [17, 18].
We say cross-phenotype ‘enrichment’ exists between CAD and migraine if the degree of
deflection of the CAD Q-Q line from the expected null line is dependent on the reliability of
Fig 1. Overview of the included studies.
https://doi.org/10.1371/journal.pone.0185663.g001
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the associations with migraine. We first applied a genomic control method using only inter-
genic single nucleotide polymorphisms (SNPs) to compute the inflation factor, λGC, and
divided all test statistics by λGC as detailed in previous publications [17, 18, 20]. Next, we
constructed conditional Q-Q plots of empirical versus nominal cumulative −log10(P) values
quantiles for all SNPs and for different subsets of SNPs determined by the significance of
their association with migraine. Specifically, we computed the empirical cumulative distribu-
tion of nominal −log10(P) values for CAD for all SNPs and for SNPs with significance levels
below the indicated cut-offs for migraine (P < 0.1, P< 0.01, P< 0.001). The nominal P-values
(−log10(p)) are plotted on the y-axis, and the empirical quantiles (−log10(q), where q = 1-cdf
(p)) are plotted on the x-axis. To assess polygenic effects below the standard GWAS signifi-
cance threshold, we focused the Q-Q plots on SNPs with nominal −log10(p) < 7.3 (corre-
sponding to P> 5x10-8). The information contained in the Q-Q plots can equivalently be
reported in the form of fold enrichment plots (Fig 2c and 2d) which emphasizes how much
more likely the selected SNPs fall in each cumulative bin compared to the baseline. The
‘enrichment’ seen in the conditional Q-Q plots can be directly interpreted in terms of true
discovery rate (TDR = 1 − FDR) [26]. The analysis was repeated independently for comparison
of C4D against migraine and for CARDIoGRAM against migraine.
Fig 2. Genetic cross-phenotype enrichment of CAD conditional on migraine. (a-b) Conditional Q-Q plot
of nominal versus empirical -log10 P-values (corrected for inflation) in CAD as a function of significance of
association with migraine at the level of P 1, P < 0.1, P < 0.01 and P < 0.001. Dotted lines indicate the null-
hypothesis. (c-d) Plots showing fold enrichment for association to CAD in a given -log10 P-value bin as a
function of association with migraine.
https://doi.org/10.1371/journal.pone.0185663.g002
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Conjunction statistics—Test of association with both phenotypes. To detect loci show-
ing strong evidence of association with both CAD and migraine, we used a conjunction statis-
tical testing procedure as described in detail previously [18]. We first calculated conditional
FDRs, defined as the posterior probability that a given SNP is null for the first phenotype given
that the P-values for both phenotypes are as small as or smaller than their observed P-values.
We assigned a conditional FDR value for each SNP in migraine given its P-value in CAD
(denoted as FDR MIG|CAD), and in CAD given its P-value in migraine (FDRCAD|MIG). Using
these, we constructed a bidirectional 2D conjunctional FDR look-up table (FDRMIG & CVD)
computing the maximum conditional FDR in both directions, i.e.,
FDRMIG&CVD ¼ maxðFDRMIGjCVD; FDRCVDjMIGÞ:
Subsequent interpolation of the look-up table yields the desired conjunction statistic. By
down-weighting single phenotype effects driving the common association signal, the conjunc-
tion statistic allows the identification of SNPs that are more likely to be associated with both
phenotypes. To illustrate the localization of the identified cross-phenotype SNPs, we used a
’Conjunction Manhattan plot’, for which we plotted the −log10(conjunctional FDR) against the
chromosomal location for all SNPs. The strongest representative from each linkage disequilib-
rium (LD) block was identified by ranking all SNPs in increasing order, based on the conjunc-
tional FDR and then removing SNPs in LD r2> 0.1 with any higher-ranked SNP, according
to the 1000 genomes LD structure [27]. The resulting SNPs are thus the ones deemed most sig-
nificant in their respective LD blocks, all of which can be taken to represent separate loci
(numbered loci). Genes close to each SNP were obtained from the NCBI gene database. A
conjunctional FDR < 0.05 was considered statistically significant.
Random LD-pruning. In order to partially account for the physiological SNP correlation
bias due to LD, all statistics illustrated above were repeatedly carried out on 100 sets of near-
independent SNPs. These were obtained by randomly selecting representatives from all LD-
blocks consisting of SNPs with pairwise LD r2> 0.1 within 1 megabase (Mb) from one
another.
DEPICT genetic enrichment analysis. To examine whether loci with evidence for cross-
phenotype association showed enrichment for specific biological pathways or tissues, we used
the DEPICT computational tool which utilizes data from 37,427 human microarray samples
for 209 tissue or cell types [28]. The analysis took as input independent SNPs with conjunc-
tional FDR > 0.4 (PLINK clumping parameters: -clump-p1 0.4—clump-r2 0.5 clump-kb 250),
corresponding to 114 SNPs comprising 192 genes for the comparison of migraine against
CARDIoGRAM and 41 SNPs comprising 75 genes for migraine against C4D. DEPICT was
run using default settings.
Characterization of identified cross-phenotype association loci. Effects of the cross-
phenotype association loci on regional gene expression (cis effect) were examined using the
Genotype-Tissue Expression (GTEx) database, a high quality database of gene expression
across various human tissues [29]. Expression quantitative trait loci (eQTLs) within a +/- 1Mb
cis window around the transcription start site for each transcript were pre-calculated in the
GTEx project, with significance determined using a Q-value threshold [29]. Previously
reported genome-wide significant associations (P-value < 5 x 10−8) at each locus were identi-
fied by considering SNPs in LD with the index SNP (r2> 0.1 in European CEU, Phase 3 of the
1000 Genomes Project [30]) represented in the NHGRI GWAS catalog [31].
Shared genetic risk between migraine and coronary artery disease
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Results
Enrichment of shared associations between migraine and CAD
Stratified Q-Q plots for CAD conditioned on nominal P-values of association to migraine
show cross-phenotype enrichment across different levels of significance for CAD (Fig 2a and
2b). Similar results were observed for C4D and CARDIoGRAM. The earlier departure from
the null line (leftward shift) indicates a greater proportion of true associations for a given nom-
inal CAD P-value. Successive leftward shifts for decreasing nominal migraine P-values indicate
that the proportion of non-null effects varies considerably across different levels of association
with migraine. For example, in the migraine P-value < 0.001 category, the proportion of SNPs
reaching -log10(PCAD)> 4 is more than 30 times greater than the −log10(PCAD) 0 category
(all SNPs) for C4D (Fig 2c), and about 20 times greater for CARDIoGRAM (Fig 2d), indicating
a high level of enrichment.
Cross-phenotype gene loci in migraine and CAD
An overlap of genetic risk factors between migraine and CAD may represent shared pathologi-
cal mechanisms between both disorders. To provide an unselected map of shared risk loci
between migraine and CAD, we performed a conjunction-FDR analysis. Three independent
loci, located on chromosomes 6 and 10, showed significant cross-phenotype association (con-
junctional FDR for index SNP< 0.05; Table 1, Fig 3).
Details of the index SNP at each locus with conjunctional FDR< 0.1 are given in S1 Table.
Locus 1 is intragenic in PHACTR1 (encoding phosphatase and actin regulator 1 protein), and
is the strongest shared risk locus between migraine and CAD in the analyses based on either
C4D or CARDIoGRAM (conjunctional FDR for index SNP = 3.50 x 10−5 and 3.90 x 10−5,
respectively). The top SNP rs9349379 is associated with the expression of PHACTR1 in various
arterial tissues (Table 2). Locus 2 is intragenic in KCNK5, a gene encoding a two-pore domain
potassium channel (conjunctional FDR = 0.021 and 0.065 in C4D or CARDIoGRAM, respec-
tively). Locus 3 is intragenic in AS3MT, that encodes arsenite methyltransferase. The locus
shows cross-phenotype association between migraine and CARDIoGRAM (conjunctional
FDR for index SNP = 0.044; not available in C4D). Top SNP rs10786719 is an eQTL for
AS3MT in heart and adrenal gland, and in cerebellum for nearby gene ARL3 (ADP-Ribosyla-
tion Factor-Like Protein 3), the SNP being located 204 kb upstream from this gene (Table 2).
Table 1. SNPs showing significant evidence (conjunctional FDR < 0.05) for shared association to migraine and coronary artery disease (CAD).
Locus Index SNP Chr Position* Nearest Gene Effect
allele
Migraine beta
(SE)
Migraine
P-value
CAD beta
(SE)
CAD
P-value
Conjunctional FDR
Comparison Migraine and CAD: C4D
Locus 1 rs9349379 6 13011943 PHACTR1 A 0.073 (0.014) 6.44E-08 -0.159 (0.017) 6.50E-21 3.50E-05†
Locus 2 rs733701 6 39279840 KCNK5 T 0.058 (0.014) 2.24E-05 0.075 (0.019) 5.86E-5 0.021†
Locus 3 rs10786719 10 104627982 AS3MT A na na na na na
Comparison Migraine and CAD: CARDIoGRAM
Locus 1 rs9349379 6 13011943 PHACTR1 A 0.083 (0.014) 7.23E-09 -0.093 (0.018) 1.54E-7 3.90E-05†
Locus 2 rs733701 6 39279840 KCNK5 T 0.057 (0.014) 7.10E-05 0.057 (0.016) 4.00E-04 0.065
Locus 3 rs10786719 10 104627982 AS3MT A -0.048 (0.013) 1.49E-04 0.052 (0.014) 2.08E-4 0.044†
SNP, Single nucleotide polymorphism; Chr, Chromosome; CAD, Coronary artery disease; FDR, False discovery rate. SE, standard error. na, SNP not
available for analysis.
*Positions refer to build NCBI36/hg18.
†Conjunctional FDR < 0.05.
https://doi.org/10.1371/journal.pone.0185663.t001
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Previously reported genome-wide significant associations at each of the three loci are given in
S2 Table.
The DEPICT genetic enrichment analysis did not identify specific tissues or biological gene
set categories significantly enriched for genes in cross-phenotype loci (S1 and S2 Figs).
As a post hoc analysis, to investigate to what extent locus 1 (in PHACTR1) was driving the
enrichment of cross-phenotype associations between migraine and CAD, we re-performed the
enrichment analysis after excluding all SNPs in PHACTR1 as well as any SNPs in LD (r2> 0.1)
with these. The resulting enrichment plots were markedly attenuated showing some residual
enrichment between migraine and CARDIoGRAM, but not between migraine and C4D
(S3 Fig).
Fig 3. Conjunction FDR Manhattan plots—Shared risk loci between migraine and coronary artery
disease (CAD). SNPs with conjunctional false discovery rate (FDR) < 0.05 are shown with large points. A
black line around the large points indicate the most significant SNP in each linkage disequilibrium block,
annotated with the closest gene. Separate plots are shown for cross-phenotype loci between a) migraine and
C4D, and b) migraine and CARDIoGRAM.
https://doi.org/10.1371/journal.pone.0185663.g003
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Discussion
In this large study based on data from 59,773 subjects with migraine or CAD we show that
genetic variants associated with migraine are also associated with CAD in excess of what
would be expected by chance. This enrichment replicated across two independent CAD
GWAS studies. Three loci, in PHACTR1, KCNK5 and AS3MT, showed significant cross-phe-
notype association.
Our results are in line with previous findings that migraine and CAD share genetic risk fac-
tors [15, 16]. One of these studies used the same migraine dataset as in the current study, but
only one of the CAD datasets (CARDIoGRAM) [15]. The other study was based on an inde-
pendent migraine dataset (23andMe) [16]. The current study also differs from previous reports
by using a novel analytical approach developed for polygenic phenotypes—the stratified condi-
tional-FDR method [32].
The three identified loci were all intragenic. Two have previously been identified as cross-
phenotype loci between migraine and CAD (locus 1 in PHACTR1 and locus 3 in AS3MT,
Table 1) [15, 16, 24], while one (locus 2, in KCNK5) is new. Post hoc analysis showed that
much of the cross-phenotype enrichment was driven by the PHACTR1 locus. The index SNPs
at two of the three loci (locus 1 in PHACTR1 and locus 3 in AS3MT) show opposite effect
directions in migraine and CAD, which corresponds with recent reports that CAD risk alleles
overall are under-represented in migraine patients [15], and that migraine risk alleles are
under-represented in CAD [16]. A GWAS of cervical artery dissection identified genome-
wide association at the exact same index SNP rs9349379 in PHACTR1 as in the current study,
with its effect in the same direction as for migraine but opposite of CAD [33]. In that study,
two additional established migraine risk variants, rs11172113 in LRP1 and rs13208321 in
FHL5, showed suggestive evidence for association to cervical artery dissection, with the same
effect direction as for migraine. The latter was subsequently reported as a cross-phenotype
locus between migraine and CAD with opposite effect directions [15]. From epidemiological
studies there is a known co-morbidity between migraine and both cervical artery dissection
[34] and CAD [9, 10], and it is intriguing that some of the same genetic variants seem to be
involved in all three disorders, but with partly opposite effect directions. Variants with oppo-
site effect direction cannot directly explain the comorbidity between migraine and CAD. How-
ever, such variants may also be of interest as they can give information on how tilting the
relevant biological system in a specific direction can predispose to one disorder while protect-
ing against the other (see e.g. [35]) or point to regulatory hubs [36]. Also, since the associated
risk variants are not necessarily the causal ones, interpretation of directionality may be con-
founded by haplotype effects, as well as heterozygous advantage, tissue-specificity, or
Table 2. Expression quantitative trait loci (eQTLs) at the identified cross-phenotype loci.
Locus Index SNP eQTL gene eQTL tissue eQTL P-value
Locus 1 rs9349379 PHACTR1 Artery—Tibial 7.2E-16
PHACTR1 Artery—Aorta 4.3E-12
PHACTR1 Artery—Coronary 8.6E-7
Locus 3 rs10786719 AS3MT Adrenal Gland 4.4E-16
AS3MT Heart—Left Ventricle 1.2E-11
AS3MT Heart—Atrial Appendage 3.4E-8
ARL3 Brain—Cerebellum 1.4E-5
Single-tissue eQTLs from GTEx database. Only eQTLs with RefSeq genes are shown.
SNP, Single nucleotide polymorphism; eQTL, Expressive quantitative-trait locus.
https://doi.org/10.1371/journal.pone.0185663.t002
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interactions with other genetic variants or environmental factors [37]. A better understanding
of the mechanisms underpinning these shared genetic associations could shed light on vascular
mechanisms in migraine and give further insight into the pathogenic basis of both disorders.
Several methods have been developed to study cross-phenotype genetic associations [13,
36]. One newly developed approach is linkage disequilibrium (LD) score regression [38]. This
method estimates shared heritability between traits based on GWAS summary statistic results,
and appears robust to overlapping samples between studies, thus conveniently allowing cross-
phenotype analysis using readily available GWAS results. A limitation of this and other meth-
ods that focus on shared heritability is that their power is proportional to the overall correla-
tion between the effects on the two traits under investigation [36]. For example, the LD-score
regression has not found any significant amount of heritability to be shared between migraine
and CAD [16]. The statistical approach applied in the current study is insensitive to the extent
of the overall correlation between the effects on the respective traits and relies only on the asso-
ciation with these. Such balanced correlation-anticorrelation scenarios may also be of biologi-
cal interest, as discussed above.
We hypothesize that genes indicated by shared loci may point to biological mechanisms
shared between migraine and CAD. The strongest shared risk locus was intragenic in
PHACTR1. This is a recognized genome-wide significant risk locus for both migraine and
CAD [23, 25, 39]. The gene product of PHACTR1, Phosphatase And Actin Regulator 1 protein,
is highly expressed in the brain where it regulates synaptic activity and dendritic morphology
[40]. It is also expressed in arteries and has a role in the regulation of endothelial function and
is associated with altered vasomotor tone [29, 41, 42]. As shown in Table 2, the index SNP
rs9349379 is associated with the expression of PHACTR1 in several arterial tissues. Both endo-
thelial and vasomotor dysfunctions have been implicated in migraine [7, 43], and the locus is
an attractive focus for future experimental studies to investigate shared pathogenic mecha-
nisms between migraine and vascular disease. Locus 2 (intragenic in KCNK5) was recently
established as a genome-wide significant locus for migraine [12]. The transcript of KCNK5
(Potassium Channel, Two-Pore Domain Subfamily K, Member 5) is a two-pore domain
potassium channel which is highly expressed in kidney [44]. Its expression in the central ner-
vous system is limited to certain brainstem nuclei and the cochlea, where its role includes che-
mosensitivity to oxygen in the central control of respiration [44, 45]. Its potential role in
migraine or vascular disease is unclear, but as it is involved in setting the membrane potential
of pulmonary artery myocytes [46], a possible role in vasomotor regulation can be hypothe-
sized. Locus 3 is intragenic in AS3MT, which encodes Arsenite Methyltransferase. A different
SNP (rs7085104) at this locus is associated with schizophrenia, and has been shown to act
through the up-regulation of a human-specific truncated isoform of AS3MT which is
expressed in neurons and astrocytes [47]. Our index SNP rs10786719 is in moderate LD with
rs7085104 in Europeans (r2 = 0.64) [30], and it possible that it could act through the same
truncated isoform of AS3MT. rs10786719 is also in LD with reported risk SNPs for several vas-
cular traits: Cerebral white matter hyperintensity burden [48], coronary heart disease and
intracranial aneurysm [25, 49], blood pressure [50], and body mass index [51] (S2 Table). The
potential pathogenic mechanism of the locus in migraine or vascular disease remains an
enigma. Three further loci showed suggestive evidence for shared association (conjunctional
FDR< 0.1, S1 Table), one of these (locus 5 near BCAR1) was previously identified as a cross-
phenotype locus between migraine and CAD [16]. Gene set enrichment analysis of a larger set
of suggestive cross-phenotype loci did not reveal enrichment in specific tissues or pathways.
This is likely a consequence of the low number of cross-phenotype loci identified.
Strengths of this study are: (i) the use of three large-scale GWAS of migraine and CAD;
(ii) the use of a statistical approach that allowed the identification of cross-phenotype
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enrichment independent of effect direction concordance, and that can pinpoint shared risk
loci; and (iii) that the results were replicated across two independent CAD studies. Certain lim-
itations should also be acknowledged: (i) while we demonstrate enrichment for cross-pheno-
type associations between migraine and CAD, further experimental evidence will be needed to
understand the biological mechanisms underpinning the identified cross-phenotype loci; (ii)
GWAS studies of migraine have been successful in identifying risk loci, but most of the associ-
ations seem to be driven by migraine without aura, and no robustly replicable loci have so far
been established for migraine with aura [12, 24]. For this reason we focused the analysis on
migraine overall, rather than on its subtypes. However, it can be envisaged that future studies
will unravel specific genetic risk factors for migraine subtypes, which would allow sub-type-
specific cross-phenotype analysis against CAD.
In conclusion, we show that genetic variants associated with migraine are also associated
with CAD, and that this enrichment replicates across two independent CAD studies. Much
of the enrichment was explained by one shared risk locus in PHACTR1, in which the index
SNP affects the risk for migraine and CAD in opposite direction. The results reaffirm previ-
ous reports, in addition to suggesting a novel shared risk locus in KCNK5. A better under-
standing of the biological mechanisms underpinning shared genetic risk loci may improve
our understanding of pathogenic mechanisms and shed light on vascular mechanisms in
migraine.
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S1 Fig. DEPICT analysis of gene expression enrichment in specific tissues. The analysis was
based on expression data obtained from 37,427 human microarray samples for 209 tissue or
cell types, as implemented in DEPICT [28]. Genes in loci with conjuctional FDR< 0.4 for
cross-phenotype association between migraine and CAD were assessed for high expression in
each of the annotation categories. The figures show the most enriched tissue types for the com-
parison of migraine against CARDIoGRAM (a) and for migraine against C4D (b). No tissue
type was significantly enriched (false discovery rate<0.05) after controlling for multiple test-
ing.
(PDF)
S2 Fig. DEPICT analysis of gene set enrichment. DEPICT reconstituted gene sets showing
strongest evidence for enrichment for genes in loci with conjuctional FDR< 0.4 for cross-phe-
notype association between migraine against CARDIoGRAM (a) and for migraine against
C4D (b). No reconstituted gene sets was significantly enriched (false discovery rate<0.05)
after controlling for multiple testing.
(PDF)
S3 Fig. Genetic cross-phenotype enrichment of migraine conditional on CAD after exclud-
ing PHACTR1. Genome-wide analysis after excluding all SNPs in PHACTR1 as well as any
SNPs in linkage disequilibrium (r2> 0.1) with these. (a-b) Conditional Q-Q plot of nominal
versus empirical -log10 P-values (corrected for inflation) in CAD as a function of significance
of association with migraine at the level of P 1, P< 0.1, P < 0.01 and P< 0.001. Dotted lines
indicate the null-hypothesis. (c-d) Plots showing fold enrichment for association to CAD in a
given -log10 P-value bin as a function of association with migraine.
(PDF)
S1 Table. SNPs showing suggestive evidence (conjunctional FDR < 0.1) for shared associa-
tion to migraine and coronary artery disease (CAD). SNP, Single nucleotide polymorphism;
Chr, Chromosome; CAD, Coronary artery disease; FDR, False discovery rate. SE, standard
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S2 Table. Previously reported genome-wide significant associations in LD (r2> 0.1) with
the identified cross-phenotype loci. LD calculations are based on the European CEU popula-
tion in the Phase 3 of the 1000 Genomes Project, as implemented in LDlink [30]. Reported
associations are taken from the NHGRI GWAS catalog [31].  PubMed ID for publication(s).
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